The market turmoil caused by rising rates and continued uncertainty has soured growth prospects in nearly every sector of the economy, including life sciences, biotech and lab real estate. After record-setting raises, cresting at $43.3B in 2021, the biotech industry started 2022 with growth curtailed, shifting expectations and venture capitalists and fund […]